five series of cases were studied. Many of the patients treated by one

Similar documents
THE LATE THERAPEUTIC RESULTS PRODUCED BY LOW VOLTAGE ROENTGEN RAYS AND OTHER FORMS OF THERAPY IN CERTAIN BENIGN CHRONIC SKIN DISEASES*

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

SKIN-CAP IN TREATMENT OF PATIENTS WITH PSORIASIS

Sandostene an(! Sandostene in Combination with Calcium: Clinical Effect in Various Dermatoses

The role of the practice nurse in managing psoriasis in primary care

The treatment of acne vulgaris with Intraderm Sulfur was reported by

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate

and virus infections notable improvements, too, have been attained in our capacity and ability to suppress inflammation, dampen the effects of allergy

Triamcinolone-Procaine in the Treatment of Zoster and Postzoster Neuralgia

TOPICAL USE OF CHLORQUINALDOL* HARRY M. ROBINSON, JR., M.D. AND MARK B. HOLLANDER, M.D. PROCEDURE

Treatment for Psoriasis with Modified Goeckerman Regimen -One Year Experience in Southern Taiwan-

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Prescribing Information

Original article Comparative study of psoralen-uvb vs. UVB-alone therapy in the treatment of psoriasis

Chemical structure of calcipotriol

EVALUATION OF TOPICAL DICHLOROXYQUINALDINE (STEROSAN) AS A THERAPEUTIC AGENT IN DERMATOLOGY* ARTHUR J. TRONSTEIN M.D.**

Psoriasis. Causes of Psoriasis

KEY MESSAGES. Psoriasis patients are more prone to cardiovascular diseases, stroke, lymphoma and non-melanoma skin cancers, and increased mortality.

Clinical Studies of Blue Cap Spray in China (2002) Blue Cap Spray in the treatment of Psoriasis. Number of patients under treatment: 144.

OBSERVATIONS ON THE EFFECT OF CORTISONE IN ACNE VULGARIS*

Topical Calcipotriol Algorithm

forniture parafarmaceutiche

A CLINICAL EVALUATION OF THE EFFECTIVENESS OF HYDRYLLIN IN THE TREATMENT OF A VARIETY OF DERMATOSES*

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

THE TREATMENT OF VITILIGO WITH AMMI MAJUS LINN*

Corporate Medical Policy

50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).

DOVONEX (calcipotriene) Cream, 0.005% Rx only FOR TOPICAL DERMATOLOGIC USE ONLY. Not for Ophthalmic, Oral or Intravaginal Use.

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

Prescribing Information. Taro-Clobetasol. Taro-Clobetasol

Featured Topic: Angelica archangelica (5 slides)

GROUP 15 TOPICAL PREPARATIONS

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

THE BACTERIA RESPONSIBLE FOR APOCRINE ODOR*

The Ointment is back!

Dermatology GP Referral Guidelines

STUDIES OF THE ETHER-SOLUBLE SUBSTANCES ON THE HUMAN SKIN

A systematic review of treatments for severe psoriasis Griffiths C E, Clark C M, Chalmers R J, Li Wan Po A, Williams H C

FUNDAMENTALS OF FAMILY THEORY 8. SOCIETAL EMOTIONAL PROCESS & EMOTIONAL CUT-OFF

Phototherapy, Photochemotherapy and Photodynamic Therapy for Dermatologic Conditions

It is estimated that about 26,000 new cases of

Enstilar , Version 3 PUBLIC SUMMARY OF RISK MANAGEMENT PLAN

Eczema. By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University

If you are looking for the book by Donna Flinn;Eczema;Eczema Remedies;Eczema Cure;Eczema Free Books;Eczema For Women;Eczema Guide;Eczema Menu and

Chapter IV: Percutaneous Puncture of Spinal Cord Cysts

Keywords: Psoriasis vulgaris Zinc pyrithione Betamethasone dipropionate

Efficacy of Concomitant Use of PUVA and Methotrexate in Disease Clearance Time in Plaque Type Psoriasis

Dr Ravi C. Ratnavel DM (Oxon) FRCP (UK)

PHARMACY PRACTICE I PHCY280 (2 CREDITS); PHCY280L (1CREDIT) SUMMER Christy Mary Sam

Clinical Policy: Phototherapy and Photochemotherapy for Dermatological Conditions Reference Number: CP.MP. 441

Diagnosis And Treatment Of Seborrheic Dermatitis

range of factors such as climatic condition, geographical location, genetic makeover, hygienic standards, age,

CUTANEOUS SENSORY THRESHOLD STIMULATION WITH HIGH FREQUENCY SQUARE-WAVE CURRENT II. THE RELATIONSHIP OF BODY SITE AND OF SKIN DISEASES TO THE SENSORY

Clinical Policy: Laser Therapy for Skin Conditions Reference Number: CP.MP.123 Last Review Date: 08/17

Photochemotherapy MM /09/2004. HMO; PPO; QUEST Integration June 1, 2016 Section: Medicine Place(s) of Service: Home; Office

Phototherapy, Photochemotherapy and Photodynamic Therapy for Dermatologic Conditions

Blue light therapy. Blue light therapy has shown to have a positive effect on the following: Why to choose blue light?

Atopic Eczema with detail on how to apply wet wraps

Psoriasis in Childhood

Dr Emmy Babor GPSI Dermatology

LEUKOPENIA, A COMPLICATION OF CHLOROMYCETIN THERAPY OF CHRONIC DISCOID LUPUS

RECENTLY Crile' reported an investigation of the local application of heat

Novan Announces Promising Clinical Results with SB414

The Role of Low-Potency Topical Steroids in Day-to-Day Practice

A STUDY OF AN ANTIHISTAMINE WITH DELAYED ACTION IN THE TREATMENT OF PRURITIC DERMATOSES

PUVATHERAPY tor PSORIASIS AND OTHER SKIN DISEASES

Clinical profile of skin diseases in accident and emergency department attenders

EFFICACY AND SAFETY OF CLOBETASOL PROPIONATE SHAMPOO IN THERAPY OF PSORIASIS OF THE SCALP

An otherwise healthy 12-year-old

Commonly Coded Conditions in Dermatology

PDP SELF-TEST QUESTIONNAIRE PSORIASIS. Plaque a raised lesion where the diameter is greater than the thickness. Number 2

ustekinumab (Stelara )

NORMAL SKIN REACTIONS TO ULTRAVIOLET LIGHT

Psoriasis: Causes, Symptoms, And Treatment

Difference Between Seborrheic Dermatitis and Psoriasis

Disorders of the vulva

Treatment of Graves Disease by the Atomic Cocktail by Malcolm R. Powell, M.D., F.A.C.P, F.A.C.N.P

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Dermclinic

Single Technology Appraisal (STA) Tildrakizumab for treating moderate to severe plaque psoriasis

D E R M A T O L O G Y

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

The Safety and Efficacy of Ondansetron in the Treatment of Obsessive Compulsive Disorder

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:

Hospital. In view of the improvement noted by Kabat and Knapp

THE use of radioactive iodine as a treatment of choice for the hyperthyroidism

PSORIASIS AND MYCOSIS FUNGOIDES OCCURRING IN THE SAME PATIENT, BOTH CONDITIONS PROVED HISTOLOGICALLY

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis

PRE-CARE & POST CARE FOR ALL TREATMENTS

DIPROSONE OV Cream and Ointment do not contain preservatives, parabens or lanolin.

experimental cutaneous cancers due to tars, scarlet red, to photosensitizing SOME EXPERIMENTAL APPROACHES TO CANCER

Ustekinumab (Stelara )

produced very few allergic reactions so that the method was abandoned. As a result, in order to demonstrate

DESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S

What's New in Oncodermatopathology: Immunotherapy Reactions

Effects of the the EPI (Extraction of Pathological Information) treatment method on grass pollen allergy and dairy product intolerance

THE RELAPSE IN SCARLET FEVER

THE EFFECTS OF PYRIDOXINE (VITAMIN B6) ON PERSISTENT

Psoriasis Penis - A Two Case Report

Making decisions about available treatments

Transcription:

PHOTOSENSITIZATION IN THE TREATMENT OF PSORIASIS' ERVIN EPSTEIN, M.D. Oakland, Calif. Reviewing the symposium on the "Practical Management of Psoriasis" (1) one is impressed by the popularity gained by the simultaneous use of photosensitizing agents and ultraviolet radiation. Of the seven contributors to this symposium; six praised such methods. The Goeckerman treatment (2) employing a crude coal tar ointment in conjunction with ultraviolet light therapy is admittedly efficacious but presents the disadvantage of the messiness of the ointment. Tulipan (3) in 1941 reported the results obtained in 11 patients with severe psoriasis in whom the ingestion of sulfanilamide and the application of a crude coal tar paint were employed as photosensitizing agents. He stated that each case showed improvement within one week and in most instances the lesions completely disappeared within a few weeks. In attempting to evaluate Tulipan's method, controls were necessary. Therefore, five series of cases were studied. Many of the patients treated by one method were later retreated by another method. A relapsing disease such as psoriasis lends itself to such comparisons. ULTRAVIOLET LIGHT PLUS SULFANILAMIDE AND CRUDE COAL TAR PAINT THERAPY Treatments were administered from 1 to 3 times a week. The patient was instructed to paint a liquid containing 10% crude coal tar and 20% acetone in benzine on all of the lesions on the morning before treatment and on the morning of the ultraviolet light treatment. In addition, 5 grains (0.3 grams) of sulfanilamide was administered orally 4 times on the day before the treatment. The patient was then exposed to generalized radiation from a hot quartz lamp without filtration. The initial exposure consisted of suberythema doses; these were gradually increased. Eleven ambulatory patients were studied in this survey. Eight were women, three men. The ages varied from 14 to 53 years, the average being 34.1 years. The duration of the psoriasis ranged from 6 months to 25 years, four having had the condition for more than 20 years. Seven had received x-ray therapy while eight were previously treated by ultraviolet radiation without photosensitizers. Only one patient was previously untreated. Large plaques were present in ten of the cases. In six the eruption could be classified as generalized while in five it was comparatively localized. Pruritus was a distressing symptom in only two instances. All of the patients showed some improvement within the first three treatments. In one case, a 14-year-old girl with plaques on her scalp, right elbow and legs, the improvement ceased after the third treatment and seven additional exposures were ineffective in altering the lesions. I Received for publication August 5, 1946. 203

204 THE JOURNAL OF INVESTIGITIVE DERMATOLOGY In two patients, marked improvement was obtained but both discontinued treatment prematurely. A girl of 14 years received seven treatments and was well on her way to recovery. The eruption cleared completely soon afterward with local therapy only. Another woman of 36 years received only five treatments for a severe, generalized eruption. She improved 75% but the treatments were interrupted when she moved to Arizona. The author is inclined to believe that both of these patients would have cleared completely if the treatments had been continued. This is based on the improvement obtained in the number of treatments given. In the other eight, at least temporary eradication of the dermatosis was obtained. In four patients, the eruption was generalized while in the other four TABLE 1 Comparison of five methods of treating psoriasis NUMBER 05 TREATMYNTS DAYS TJNDER TREATEENT RESULTS BEE CASES Cleared Marked Moderate "Eff Poor tive Improv. improv. % U.V.R. + 11 6 3014.2 9 75 57.88 (82.7%) 3(27.3%) 0 1 (9.1%) 90.9 tar + sulfanilamide U.V.R. + 4 21 2624.0 41 49 45.74 (100%) 0 0 100 sulfanilamide 1J.V.R.+ 11 3 6020.9 13395111.84 (36.2%) 5(45.5%)2(18.2%)o 81.7 tar IJ.V.R. 9 4 3616.1 69305147 2 (22.2%) 0 1(11.1%)6(66.6%) 22.2 X-ray 23 3 12 8 23278119.49 (39.0%) 10(43.5%) 3(13%) 1(4.3%) 82.5 it was limited to localized areas. The latter group manifested involvement of the scalp in two instances while the arms and legs were affected in three. In this group, the number of treatments varied from 6 to 30, five patients requiring more than 15. The average for the group was 14.2 treatments each. In one instance, the relief of pruritus preceded visible changes in the lesions, while in another, the itching persisted until the dermatosis had nearly cleared. COMPARISON WITH OTHER METHODS As stated previously, the method studied was compared with other related therapeutic regimes in an attempt to evaluate its worth. Table 1 outlines the results obtained by the five methods considered. It is felt that an "effective rate" can be established by combining the cases that were completely cleared with those showing marked improvement (85% or more clearing.) Many of the cases in the latter category probably would have undergone a complete remission

PHOTOSENSITIZATION AND PSORIASIS 205 if the treatments had been continued. In fact, when seen at a later date, many of the patients included in the "marked improvement" category stated that the psoriatic eruption had completely subsided soon after they had discontinued treatment. Each method of treatment will be considered individually. ULTRAVIOLET LIGHT WITHOUT PHOTOSENSITIZATION The "effective rate" of 22.2% indicates that this method is a comparatively ineffective approach. This rate was obtained despite the fact that the average patient remained longer under treatment with ultraviolet light alone (147 days) than with any other regime studied. It is felt that in the average case, ultraviolet light therapy needs "reinforcement" such as that furnished by photosensitizing agents. ULTRAVIOLET LIGHT WITH SULFANILIADE The results in this series are not considered significant. The cases were hospitalized, a factor not employed in the other groups. The patients were treated three times a week in contradistinction to the others receiving light or radiation therapy once or twice a week. Moreover four cases is too small a series for drawing conclusions. However, when compared to the results obtained with heliotherapy alone, the results suggest that sulfanilamide may be of value in this type of treatment. ULTRAVIOLET LIGHT WITH TAR The "effective rate" of ultraviolet light plus the crude coal tar paint mentioned above is about the same as that of x-ray therapy (81.7% vs. 82.5%) but less than that of ultraviolet radiation combined with tar and sulfanilamide (81.7% vs. 90.9%.) This further suggests that the sulfanilamide is a beneficial factor in this regime. By employing ultraviolet light with tar, one avoids the possibility of sulfonamide by-effects and still obtains results comparable to those secured with roentgen ray treatments. However, it is necessary to give more treatments than with the latter method (20.9 vs. 8) although the time involved is about the same (111.8 vs. 119.4 days.) This type of treatment is indicated when the physician is anxious to avoid the possibility of sulfonamide by-effects, as in a patient with known tendencies to sulfonamide intolerance and for whom x-ray therapy is not applicable. It is probably the safest effective method. X-RAY THERAPY The treatment of psoriasis with roentgen rays is often condemned. This disfavor is based on the dangers of repeated, indiscriminate irradiation and on the belief that adequate results can be obtained by other methods. This study confirms the latter belief. However, the careful application of x-rays in the hands of an expert is probably of less danger than the use of sulfonamides. Certainly the risk of accurately controlled radiation is less than the vagaries of sulfonamide idosyncracy. This, of course, does not apply to uncooperative,

206 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY unintelligent patients who may hide knowledge of previous treatment to obtain further x-ray therapy. However, it is a simple matter to teach the average patient the dangers of such a course. The advantages of x-ray therapy can be seen to be a high degree of effectiveness (82.5%); necessity for fewer treatments (8 vs. 14.2); and the elimination of "messy" tar preparations. DISCUSSION From the foregoing and from the report of Tulipan, it is obvious that his method constitutes an effective method of eradicating the lesions of psoriasis. However, even this limited experience has demonstrated that recurrences are just as frequent as with other modes of treatment. A major advantage is that the treatment apparently can be repeated indefinitely. This limitation of repeated use is the biggest disadvantage to the employment of roentgen rays in psoriasis, a relapsing disease. Furthermore, the ultraviolet-tar-sulfonamide combination seems to be as effective in combatting recurrences as it is the first time it is employed in a given patient. While there is some odor to the local medication and while it has a tendency to rub off on clothing, it is much less objectionable than an ointment. Neither Tulipan nor I have noted serious reactions to sulfanilamide in these patients, but such a possibility can not be discounted. The side-effects of the sulfonamides are too well known to require elaboration here. Eruptions associated with the photosensitizing action of these drugs are commonly observed in the treatment of various infections. Furthermore, ill effects from ultraviolet rays and from light have long been recognized. (I had the opportunity to observe a patient dying of porphyrinuria following an ultraviolet light treatment given by a chiropractor. Fortunately, such accidents are rare. However, there is a definite risk to this type of therapy despite the small doses of su]fanilamide used. Anyone employing this method should be conversant with the risks inherent in it). Since photosensitizing agents have been used in the treatment of psoriasis for about twenty years, one wonders why it has not been used more extensively in other conditions responding to ultraviolet radiation. I have noted encouraging results in the following dermatoses with the herein described method: seborrheic dermatitis, pruritus ani, pruritus vulvae, pityriasis rosea, eczema and acne vulgaris. SUMMARY AND CONCLUSIONS The series reported is too small to allow for sweeping generalizations or dogmatic statements. Its main value lies in the attempt to compare the results obtained by a number of related therapeutic measures. The effect was correlated with the number of treatments and time under treatment with each regime. An estimation of relative effectiveness was obtained by combining the percentage of cases clearing completely with those obtaining marked improvement. This study suggests that the following statements are justified. 1. The treatment of psoriasis with ultraviolet radiation combined with the

PHOTOSENSITIZATION AND PSORIASIS 207 local application of a crude coal tar paint and the ingestion of sulfanilamide is the most effective method investigated. The estimated effectiveness is roughly 90%. It is impossible to compare this with the results reported by Goeckerman because the latter's cases were hospitalized and the oniy statement made in his article is that there were only 3 failures in 181 cases. 2. Sulfanilamide adds to the therapeutic results. This was demonstrated by the comparison of the series given ultraviolet light alone with the series in which the heliotherapy was augmented by the oral administration of sulfanilamide. This was further confirmed by comparing the ultraviolet-light-with-tar series with the ultraviolet-radiation-tar-sulfanilamide group. While sulfonamide by-effects were not encountered in this series, the possibility of such a development is constantly present even with the small doses employed. 3. The treatment of psoriasis with x-rays is about equal in efficiency to the results obtained by the combined use of ultraviolet radiation with crude coal tar paint. The former method presents the advantages of cleanliness, necessity for fewer treatments and lack of systemic toxicity when administered by a competent specialist. The latter presents advantageous features also. These include the avoidance of possible sulfonamide reactions and the elimination of a possible radioderinatitis. Both methods have an estimated effectiveness of about 80%. 4. Ultraviolet light without adjuvant photosensitization is a comparatively ineffective means of treating psoriasis. BIBLIOGRAPHY 1. AYERs, S., BECKER, S. W., CHARGIN, L., CORNELEET, T., Fox, E. C., MADDEN, J. F., O'LEARY, P. A.: Symposium on the practical management of psoriasis. J. Invest. Dermat., 4:399 (Oct.) 1941. 2. GOECKEBMAN, W. H.: Treatment of psoriasis. Arch. Dermat. & Syph., 24: 446 (Sept.) 1931. 3. TULIPAN, L.: Treatment of psoriasis with photosensitizing agents. Arch. Dermat. & Syph.,43:99 (Jan.) 1941.